Ground-breaking ArcEquine Ambassador network launches

The exceptional customer service supporting its unique ArcEquine microcurrent unit is to be enhanced further by manufacturer ARC Microtech (ARC) with the ground-breaking launch of a new network of highly skilled product Ambassadors.

Over £1,000,000 and 23,000 hours of product development in the technologically advanced ArcEquine unit have resulted in what is the smallest, wide spectrum microcurrent device in the world. Drug free, non-invasive and easy to use, it rapidly reduces swelling, bruising, inflammation and pain, stimulating tissue regeneration and repair across a wide spectrum of equine injuries.

Having quickly gained global credibility with elite riders and their expert advisors in 14 different countries, the next phase of the company’s meteoric growth will include the roll-out of what CEO Peter Clayton describes as; “a ground-breaking new business service”. 

He explains; “Our Ambassador concept will enable equine healthcare professionals and the equine supply chain to offer additional services to horseowners resulting from opportunities that will deliver new revenue streams and healthy margins to their businesses. ArcEquine Ambassadors will have expertise in the technology behind the ArcEquine and its practical use by horseowners, along with skills to support equine trade and healthcare professionals in developing both proficiency in its application and associated growth in their businesses. As a team, they herald a completely new level of customer service for the equine industry that will rival well-known global consumer brands.”

The first ArcEquine Ambassadors have been appointed and are already working with equine vets, physiotherapists, chiropractors, farriers, tack shops, rehabilitation centres and trainers to help them bring the benefits of ArcEquine microcurrent therapy to their clients and also their businesses.

 
Further Ambassador appointments will follow in coming weeks and months to support the accelerating growth in trade relationships. 

Anyone interested in the opportunities at any level should contact ARC’s Head Office on 01580 755504.

Peer reviewed publication confirms quality of ArcEquine research

ARC Microtech Ltd's (ARC) ArcEquine unit is the result of an £850,000 nine-year programme of research and development and the company’s proven expertise in the equine sector has resulted in acceptance of two peer-reviewed articles for publication by the Journal of Equine Veterinary Science.

‘Equine Hoof Management and the Client-Farrier Relationship in the UK’ discusses the prevalence of hoof health problems over a 5-year period, the importance of the farrier-veterinarian relationship and the impact of nutrition. The data concludes that the owner-reported frequency of hoof abnormalities is significantly higher than reported in previous studies, suggesting an encouraging increase in owner awareness, whilst highlighting the need for further research and collaboration amongst professionals to further optimise hoof health.

‘Examining Attitudes Towards Equine Complementary Therapies for the Treatment of Musculoskeletal Injuries’ considers causes of career-ending injuries amongst equine athletes and assesses the usage and perceived efficacy of complementary and alternative veterinary medicine (CAVM). This includes a variety of diagnostic and therapeutic treatments increasingly used by owners with the expectation of facilitating complete healing and enhanced recovery rates. Data suggests owners are highly influenced by their veterinarian and concludes that further randomised, controlled research trials will support increased adoption of effective treatment modalities.

Authored by ARC Director of Research & Development, Jack Thirkell and Rebecca Hyland, these peer reviewed articles report two of a number of research projects currently being funded by the company. Jack Thirkell explains; “We have an ongoing programme of research exploring different therapeutic applications of microcurrent technology, both in the laboratory and in the field. We will be sharing more of our findings in coming months and are looking forward to working more closely with equine vets and allied healthcare practitioners.”

Find out more online at www.arcequine.com or contact the ARC Microtech head office on 01580 755504.